Menopause: The Journal of The North American Menopause Society Vol. 25, No. 3, pp. 357-358 DOI: 10.1097/GME.0000000000001044 2017 by The North American Menopause Society LETTERS TO THE EDITOR To the Editor: We read with interest the recently published article by Cruz Simone Ferrero, PhD, et al entitled ‘‘Randomized, double-blind, placebo-con- Academic Unit of Obstetrics and Gynaecology IRCCS Ospedale Policlinico San Martino trolled clinical trial for evaluating the efficacy of fractional Genoa, Italy CO laser compared with topical estriol in the treatment of Department of Neurosciences, Rehabilitation vaginal atrophy in postmenopausal women’’. Ophthalmology, Genetics, Maternal and Child Health This study aimed to evaluate the efficacy of fractional CO (DiNOGMI) vaginal laser treatment and compare it with local estrogen University of Genoa therapy, and the combination of both treatments for vulvovaginal Genoa, Italy atrophy (VVA). The regenerative effects of intravaginal frac- tional CO laser on the vaginal epithelium and lamina propria in REFERENCES postmenopausal women with VVA were previously reported. Microablative fractional CO laser has been demonstrated to be 1. Cruz VL, Steiner ML, Pompei LM, et al. Randomized, double-blind, feasible, efficacious, and safe in improving VVA-related symp- placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with
Menopause – Wolters Kluwer Health
Published: Mar 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera